<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The aim of this study was to investigate the neuroprotective effects of <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> after severe forebrain ischemic injury </plain></SENT>
<SENT sid="1" pm="."><plain>We also examined the relationship between the duration of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and neuronal cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Male Sprague-Dawley rats (300-380 g) were subjected to 6 (each n = 6) or 10 min (each n = 10) of near-complete forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> while anesthetized with either 50 mg/kg of zoletil given intraperitoneally or inhaled <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> (2.3%) </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">Ischemia</z:e> was induced by bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> plus hemorrhagic <z:hpo ids='HP_0002615'>hypotension</z:hpo> (26-30 mmHg) </plain></SENT>
<SENT sid="4" pm="."><plain>Histologic outcomes were measured 7 days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in CA1 pyramidal cells of the rat hippocampus </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The mean percentage of necrotic cells in the hippocampal CA1 area decreased in the <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> group compared to the zoletil group (25% vs. 40% after 6 min <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, respectively: P = 0.004 and 44% vs. 54% after 10 min of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, respectively P = 0.03) </plain></SENT>
<SENT sid="6" pm="."><plain>The percentage of apoptotic cells was similar in <z:hpo ids='HP_0000001'>all</z:hpo> groups </plain></SENT>
<SENT sid="7" pm="."><plain>The percentage of necrotic cells in each <z:chebi fb="164" ids="38867">anesthetic</z:chebi> groups was significantly higher in the 10 min <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> group compared to the 6 min <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> group (P = 0.004 in the <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> group, P = 0.03 in the zoletil group) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: The present data show that <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> has neuroprotective effects in rats subjected to near-complete <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Longer duration of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> is associated with more neuronal injury when compared to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> of shorter duration </plain></SENT>
</text></document>